Terry Porter
SVP Business Development at Seal Rock Therapeutics | Greater Chicago Area, United States
Terry Porter’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
SVP Business Development at Seal Rock Therapeutics in February 2017 - Present
VP, Search & Evaluation, Global Business Development at Takeda Pharmaceuticals in December 2011 - December 2016
Managing Director at Aqua Partners, LLC in December 2009 - January 2012
VP External Science & Technology, Worldwide Business Development at GlaxoSmithKline in October 2006 - August 2010
Senior Director, Head of Oncology Licensing, Worldwide Business Development at GlaxoSmithKline in January 2000 - October 2003
Assistant Director, Protein Biochemistry at SmithKlineBeecham in January 1991 - January 1996
Senior Scientist at Seragen Inc in January 1986 - January 1988
Seal Rock Therapeutics is a clinical-stage company developing novel therapeutics for diseases of high unmet need. Seal Rock’s pioneering LRRK2/ASK1 signaling complex (LASC) inhibitors are disease modifying agents for Parkinson's disease and ALS by blocking multiple causal pathways and severing feedback loops that cause neurodegeneration and neuroinflammation. Several are now in preclinical development. The ASK1 inhibitor SRT-015 has shown excellent safety and efficacy in a phase 1 trial. We are developing oral SRT-015 for cirrhosis and rare liver diseases, and our partner Genfit is developing it for acute-on-chronic liver failure.condition resulting from fatty liver disease, characterized by hepatic inflammation and cellular damage that lead to liver fibrosis. Additional opportunities with ASK1 inhibitors include cardiac, immunological and neurodegenerative indications.
Discover more about Seal Rock TherapeuticsDirector of Chemistry at Seal Rock Therapeutics
Director Of Chemistry at Seal Rock Therapeutics
(May 2016 – Present)
CEO at Seal Rock Therapeutics
Seal Rock Therapeutics, Inc. is a clinical stage company developing small molecule kinase inhibitors. Seal Rock’s most advanced program is a phase 2-ready, liver-directed ASK1 inhibitor being developed for acute and chronic liver disease. Seal Rock’s next program is a gr...
Co-founder and Vice President at Seal Rock Therapeutics
Seal Rock Therapeutics, Inc. is a discovery stage company developing small molecule inhibitors to a protein that mediates apoptosis, inflammation, and fibrosis. Seal Rock is focusing its efforts on NASH (non-alcoholic steatohepatitis), a condition resulting from fatty liver d...
Dishwasher en Seal Rock Therapeutics
Dishwasher at Seal Rock Therapeutics
(Present)
What is Terry Porter email address?
Email Terry Porter at [email protected] and [email protected]. This email is the most updated Terry Porter's email found in 2026.
What is Terry Porter phone number?
Terry Porter phone number is 3096430727.
How to contact Terry Porter?
To contact Terry Porter send an email to [email protected] or [email protected]. If you want to call Terry Porter try calling on 3096430727.
What company does Terry Porter work for?
Terry Porter works for Seal Rock Therapeutics.
What is Terry Porter's role at Seal Rock Therapeutics?
Terry Porter is SVP Business Development
What industry does Terry Porter work in?
Terry Porter works in the Biotechnology industry.
